Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Thailand Leads Longevity Tourism with 90‑Day Visas and Low‑Cost Regeneration
Thailand’s Tourism Authority has positioned the kingdom as the world’s premier longevity‑tourism destination, rolling out 90‑day multi‑entry medical visas and marketing the slogan “Healing is the New Luxury.” The move couples high‑tech clinics with cultural practices, delivering regenerative programs that cost roughly 60% less than comparable services in the United States or Europe.
CRN Foundation’s Prenatal Nutrition Center Draws Standing‑Room‑Only Crowd at ACOG 2026
The Council for Responsible Nutrition (CRN) Foundation’s Prenatal Nutrition Center pulled a standing‑room‑only audience at the American College of Obstetricians and Gynecologists (ACOG) 2026 meeting, highlighting clinicians’ appetite for science‑backed supplement guidance. Backed by major supplement manufacturers, the booth became...
Predicting Alzheimers & Dementia (and Minimizing Risk)
Recent research highlights a multi‑pronged approach to predicting and preventing Alzheimer’s and other dementias. Large meta‑analyses show routine adult vaccinations can lower dementia risk by up to 40%, while a novel drug combo (ACX‑02) demonstrated rapid clearance of amyloid and...
Study Finds ‘Super Shoes’ Boost Speed but May Heighten Injury Risk for Elite Runners
Researchers at Mass General Brigham studied 23 elite distance runners and found that advanced footwear technology—so‑called “super shoes”—significantly improves race‑pace speed while decreasing cadence and increasing overstriding, factors linked to higher bone‑stress injury risk.
Resilia Tissue Developed by Edwards Lifesciences Associated with Long-Term Durability
Edwards Lifesciences presented 10‑year results from the COMMENCE surgical aortic valve trial, showing its Resilia tissue leaflets achieve 97.9 % freedom from structural valve deterioration. The technology combines calcium‑blocking chemistry with dry storage to limit calcification, delivering stable hemodynamics and low...
Celcuity’s Gedatolisib Beats Novartis’ Piqray in Phase III Advanced Breast Cancer Trial
Celcuity announced that its PI3K‑mTOR inhibitor gedatolisib achieved a progression‑free survival benefit versus Novartis' alpelisib (Piqray) in a Phase III study of advanced breast cancer patients with PIK3CA mutations. The data could reshape treatment options for a disease that affects millions...
Asthma-Related ER Visits Spike in Baltimore After Nighttime Heatwaves
Johns Hopkins researchers found a clear surge in asthma‑related emergency‑room visits in Baltimore weeks after nighttime heat waves hit neighboring communities. The study, published in GeoHealth, shows that the city’s Code Red Extreme Heat alert, which only tracks daytime temperatures, overlooks...
Stakeholders Await Impact Of Swift Provider Revalidation
The Centers for Medicare & Medicaid Services (CMS) has announced a swift provider revalidation mandate targeting home and community‑based service providers. Stakeholders, including provider groups and patient advocates, say it is too early to assess the policy’s impact on workforce...
FDA Vaccine Studies Censored by Trump Admin After Finding Benefits of Shots
The Food and Drug Administration, under the Department of Health and Human Services, blocked the publication of two internal studies that demonstrated the safety and efficacy of COVID‑19 vaccines, and prevented two Shingrix (shingles vaccine) abstracts from being presented at...
431. ALCOHOL AT ANY DOSE CAUSES CANCER, VIOLENCE, AND SHRINKS YOUR BRAIN
The episode dismantles the myth that moderate alcohol consumption is safe, citing the 2018 Global Burden of Disease Study and subsequent research that show any level of drinking increases risk of cancer, brain atrophy, cardiovascular damage, and death. It details...
May 6, 2026 – The Week in Health Care News
The 5th U.S. Circuit Court upheld Louisiana's challenge to FDA rules, issuing a national stay that blocks telehealth prescribing of the abortion pill mifepristone, though the Supreme Court granted a temporary stay until May 11, restoring limited access. Polling shows roughly...
The Future of Healthcare Is About Giving Back Attention
Healthcare providers are facing an "attention crisis" as clinicians juggle patients, screens, and endless alerts. While AI promises speed and scale, the real need is for tools that reclaim clinicians' time rather than add features. athenaInstitute’s study shows 63% of...
NYC Health Department Launches Anti-Alcohol ‘Buzzkill’ Campaign
The New York City Department of Health launched the "Buzzkill" campaign, a city‑wide effort to warn residents that alcohol consumption raises the risk of cancers in the breast, colorectum, esophagus, liver, mouth, throat and voice box. The initiative uses ads...
Pfizer Posts $14.5 B Q1 Revenue, Reaffirms 2026 Guidance
Pfizer announced first‑quarter 2026 revenue of $14.5 billion, a 5% year‑over‑year increase, and a 22% rise in operational revenue from launched and acquired products. The company reaffirmed its full‑year 2026 financial guidance while highlighting progress in oncology and obesity pipelines.
Tofersen, a New Treatment for A.L.S., Reverses Symptoms for Some
Tofersen, the first FDA‑approved therapy targeting the SOD1 genetic form of ALS, is showing functional gains in a subset of patients. In a case highlighted by the New York Times, 58‑year‑old Amanda Sifford’s lung capacity rebounded from 48% to 86%...
LTZ Therapeutics Secures $38M to Advance Myeloid Engager Immunotherapy Pipeline
LTZ Therapeutics announced an oversubscribed $38 million financing round led by GL Ventures, bringing its total capital to roughly $130 million since 2022. The funds will propel the Universal Myeloid Cell Engager (U‑MCE) platform, supporting the Phase 1 trial of lead bispecific antibody...
We’re Finally Recognizing ADHD‑autism Comorbidity, Not Creating New Neurodiversity
Until 2013, you officially couldn't be diagnosed with both ADHD & autism at the same time. The diagnostic criteria treated them as mutually exclusive. Entire populations of people with both were told they had neither (or something else entirely) because the system's...
COVID-19 Prevention Gaps in Immunocompromised Patients: Muhammed Bilal Abid, MD
Dr. Muhammed Bilal Abid highlighted persistent COVID‑19 prevention gaps for immunocompromised patients, especially those with chronic lymphocytic leukemia (CLL). He cited the CANOPY trial, which reported zero symptomatic COVID‑19 cases over six months in a small CLL cohort receiving the monoclonal antibody...
Latus Bio Secures $97 Million Series A to Scale Gene‑Therapy Access
Latus Bio closed a $97 million Series A financing, with a $43 million extension led by 8VC, to accelerate its AAV‑based gene‑therapy pipeline. The capital will fund IND filing for Huntington’s disease candidate LTS‑201 and a CLN2 trial, underscoring investor confidence in...
Cannabis Execs Anticipate Tax Benefits From Rescheduling
The DOJ and DEA reclassified medical cannabis as a Schedule III drug on April 23, ending its Schedule I status. This change eliminates the IRS 280E restriction for medical cannabis businesses, potentially cutting tax burdens by up to half. Industry leaders Curaleaf and Green...
Patients Pay when Medicare Care Coordination Codes Go Unused
Medicare’s 2024 Physician Fee Schedule introduced two new reimbursement categories—Community Health Integration and Principal Illness Navigation—to fund care coordination and navigation for high‑risk patients. Two years later, most primary‑care practices have not adopted these codes due to awareness gaps, workflow...
Conversational AI Shows Promise in Easing Symptoms of Anxiety and Depression
A randomized trial of 995 Israeli university students found that a conversational AI mental‑health app, Kai, produced greater reductions in anxiety and depression than traditional face‑to‑face group therapy and a wait‑list control over a 12‑week period. The AI group also...
Moss Powering the Next Drug Frontier
Eleva is commercializing a moss‑based biomanufacturing platform that can produce complex glycoproteins difficult to express in traditional CHO or yeast systems. The German firm has advanced its first candidate, a recombinant alpha‑galactosidase for Fabry disease, into clinical trials and is...
First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s
A microrobotic surgery trial for Alzheimer’s disease began at Baptist Health in Jacksonville, treating the first patient with moderate disease. Medical Microinstruments Inc. (MMI) plans to enroll 15 participants and monitor them for a year, aiming to clear cervical lymph‑node...
Financings for May 6, 2026
UK‑based Cytospire Therapeutics announced a £61 million (≈$82.7 million) Series A round to accelerate its EGFR‑targeted T‑cell engager pipeline for solid tumours. The capital backs multiple pre‑clinical programs and reflects strong investor confidence in next‑generation immunotherapies. Bio Korea 2026 highlighted a shift in...
Examining the Distinct Effects of Structural, Financial, and Information-Sharing Integration on Hospital Costs
A recent panel study of 427 California hospitals (2014‑2016) examined three integration dimensions—structural, financial and information‑sharing—and their impact on hospital spending. Using hospital fixed‑effects regressions, the authors found that higher financial integration, measured by the share of revenue under shared‑risk...
Other News to Note for May 6, 2026
Cytospire Therapeutics announced a £61 million (≈$82.7 million) Series A round to advance its next‑generation T‑cell engager platform targeting the epidermal growth factor receptor (EGFR) in solid tumours. The funding will accelerate pre‑clinical and early‑clinical programs aimed at delivering more selective immunotherapies. Meanwhile,...
IPLEDGE Hurdles Block some Inmates From Receiving Isotretinoin in Jails, Prisons
The FDA‑run iPLEDGE REMS program blocks many incarcerated patients from receiving isotretinoin because it requires pharmacies to register with an NCPDP number—a identifier jails and prisons do not possess. In addition, the system mandates a phone number or email for...
CCTA Brings Clarity, Better Outcomes to CTO PCI
A systematic review of 56 studies shows that coronary CT angiography (CCTA) performed before chronic total occlusion (CTO) percutaneous coronary intervention (PCI) enhances procedural planning and improves patient outcomes. The authors identified three concrete benefits: better case selection, more precise...
Testosterone Replacement for Older Men
Matt Kaeberlein, a longevity researcher and Optispan CEO, began weekly testosterone injections in his 50s after testing revealed low levels. Six years of therapy has, by his account, boosted energy, mood, body composition and overall well‑being, positioning TRT as a...
The Architecture Built While You Weren’t Looking
The World Health Organization has assembled a four‑layer pandemic governance system between 2023 and 2026, culminating in Exercise Polaris II on April 22‑23, 2026, which involved 26 countries, 600 health‑emergency experts, and AI‑enabled workforce planning tools. Layer 1 is the legally binding Pandemic...
WTWH Healthcare Announces the Future Leaders Class of 2026
WTWH Healthcare, a division of WTWH Media, announced its 2026 Future Leaders Class, recognizing professionals under 40 who are shaping aging and healthcare. The honorees span providers and vendors across sectors such as home health, behavioral health, hospice, senior living,...
Insulet Raises Revenue Expectations for 2026
Insulet Corp. raised its 2026 revenue growth outlook to 21%‑23% on a constant‑currency basis, up from the prior 20%‑22% range. The company posted Q1 revenue of $761.7 million, a 34% year‑over‑year increase, and net income of $91.1 million. Growth is being driven...
Briumvi’s Optional Subq Gives It Market‑share Edge
On the $TGTX call the following was casually mentioned in response to a question about subq: "We feel actually very confident in our ability to deliver a quarterly product." It's important to understand that Briumvi will be the only product that...
Oracle and ACRN Health Launch AI-Driven Research in Africa
This collaboration between Oracle Life Sciences and the @acrnhealth is a significant step in delivering modern, AI-driven, patient-centric research and scientific breakthroughs in Africa. https://t.co/Z26aK7wRxW
How Early Action May Reduce Fracture-Related Infections
Fracture‑related infection (FRI) affects 1% of closed fractures and up to 30% of severe open injuries, posing a costly challenge for orthopedic trauma care. Early suspicion—based on wound drainage, redness, or implant instability—enables prompt diagnosis, which markedly lowers the risk...
Real-Time AI Powers Next-Gen Operating Rooms
PeritasAI Is Bringing Real-Time #AI Intelligence Into the Operating Room by @NVIDIARobotics #Robotics #ArtificialIntelligence #Innovation #Technology https://t.co/kX2v8mdDLk
Scientists Remove Essential Amino Acid, Redefining Life's Code
All Life Uses 20 Amino Acids. Scientists Just Deleted One in Bacteria The synthetic bacteria push the limits of life and could open the door to designer proteins and new medicines https://t.co/mVZrQ0z7vz https://t.co/zFzSpnrk6h
Fathom Secures Strategic Investment From CVS Health Ventures to Scale Autonomous Medical Coding
Fathom, a leader in autonomous medical coding, secured a strategic investment from CVS Health Ventures to accelerate its platform that automates over 90% of coding tasks across multiple specialties. The company, recently named the #1 solution for Reducing the Cost...
Radiologists Draft Consent for Unproven Whole-Body MRI Screening
At @JAMA_current today, 2 radiologists publish what should be the consent form for a total body MRI in healthy people Note: "no major medical society recommends whole-body MRI screening in the general population because it is unproven, and the harms likely...
WHO and Officials Mishandle Infected Ship, Endangering Public
This is a good reminder that the WHO and government “experts“ generally responsible for keeping us safe from infectious disease are largely incompetent. They let people on an infected ship leave and get on public flights through public airports.
Carlyle Acquires Knack RCM and EqualizeRCM to Build Global AI-Native Healthcare RCM Platform
Carlyle has taken a majority stake in Knack RCM and EqualizeRCM, merging them into a single AI‑native revenue cycle management platform. The combined entity leverages Equalize’s Bill Smart denial‑prediction AI and Knack’s global delivery footprint of 8,000 staff and its...
The Convenient Narrative Letting Insurers Off the Hook
Zack Cooper’s New York Times op‑ed attributes rising premiums chiefly to hospital market power, but industry insiders contend insurers also fuel costs. The piece explains how insurer consolidation gave payers bargaining leverage that spurred hospitals to merge, creating a costly arms race....
Pill GLP‑1 Drugs Activate Amygdala Reward Circuit, Not Hypothalamus
Discovery of a new brain reward circuit in the amygdala for small molecule (pill) GLP-1 drug effect, unlike the injectables (hypothalamus), as shown in mice https://t.co/3lkfxROh5Z
EPSA: A Useful Metric Across Chemical Space
The article highlights EPSA (Experimental Polarity Surface Area) as a robust metric for assessing molecular polarity across broad chemical space. Unlike traditional PSA, EPSA is derived from supercritical fluid chromatography, offering experimental insight into a compound’s three‑dimensional polarity profile. The...
Blood Test Now Gauges Tumor Microenvironment Non‑invasively
We've known how important the tumor microenvironment is for cancer progression and treatment, but we never had a non-invasive blood test to assess it. Today, as reported @nature, one has been discovered https://t.co/rDaF5YUwTq
Veradigm Survey: Independent Practices Rely on Technology to Stay Independent
Veradigm’s March 2026 survey of 360 independent practice leaders shows that 79% view technology as essential to maintaining independence amid rising costs and administrative pressure. Over half (57%) say better automation would markedly improve performance, while 68% admit limited real‑time...
A New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells' DNA
Researchers have engineered a novel CRISPR protein, Cas12a2, that acts as a molecular shredder, destroying DNA in cells that express a specific RNA trigger. In vitro, Cas12a2 cut the growth of KRAS‑mutant lung‑cancer cells by 50% and eliminated over 90%...
Tenet to Participate in the BofA Securities Health Care Conference
Tenet Healthcare Corp. (NYSE:THC) will present at the Bank of America Securities Health Care Conference on May 13, 2026, at 6:00 p.m. ET. The session will be streamed live and archived for 30 days on Tenet’s investor‑relations website. The appearance gives...
A Low-Cost Rotavirus Test Could Save Childrens’ Lives in Nigeria
Researchers at Obafemi Awolowo University have created a low‑cost, point‑of‑care rotavirus test that works without electricity or specialized training. The nanobead‑based kit showed 88% sensitivity in pilot hospitals, beating the standard ELISA test’s 60% sensitivity. Rotavirus accounts for nearly half...